Apjohn ventures

Total investments

17

Average round size

15M

Portfolio companies

10

Rounds per year

0.94

Lead investments

1

Follow on index

0.41

Exits

4

Stages of investment
Late Stage Venture
Areas of investment
BiotechnologyHealth CareMedical DeviceMedicalLife SciencePharmaceuticalTherapeutics

Summary

In 2003 was created Apjohn ventures, which is appeared as VC. The main department of described VC is located in the Kalamazoo. The venture was found in North America in United States.

The current fund was established by Donald Parfet, Mina Patel Sooch. The overall number of key employees were 6.

We can highlight the next thriving fund investment areas, such as Therapeutics, Medical. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight CytoPherx, Svelte Medical Systems, Asterand. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Speaking about the real fund results, this VC is 13 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2015. The high activity for fund was in 2009. Opposing the other organizations, this Apjohn ventures works on 16 percentage points less the average amount of lead investments.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Apjohn ventures, startups are often financed by Lurie Investment Fund, Grand Angels, Biosciences Research and Commercialization Center (BRCC). The meaningful sponsors for the fund in investment in the same round are Lurie Investment Fund, North Coast Technology Investors, Fort Washington Capital Partners Group. In the next rounds fund is usually obtained by Lurie Investment Fund, Capital Midwest Fund, Orchard Venture Partners.

Show more

Investments analytics

Analytics

Total investments
17
Lead investments
1
Exits
4
Rounds per year
0.94
Follow on index
0.41
Investments by industry
  • Health Care (14)
  • Biotechnology (13)
  • Life Science (11)
  • Therapeutics (10)
  • Medical Device (4)
  • Show 2 more
Investments by region
  • United States (12)
  • Canada (5)
Peak activity year
2005

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
16
Avg. valuation at time of investment
11M
Group Appearance index
0.88
Avg. company exit year
7
Avg. multiplicator
1.67

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Asterand 26 Nov 2003 Biotechnology, Health Care, Life Science Late Stage Venture 3M United States, Michigan, Detroit

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.